Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema: the BRDME study

Maartje J.C. Vader; Ann-Sofie M.E. Schauwvlieghe; Frank D Verbraak; Greetje Dijkman; Johanna M.M. Hooymans; Leonie I. Los; Aeilko H. Zwinderman; Tunde Peto; Carel B. Hoyng; Redmer van Leeuwen; Johannes R. Vingerling; Annette C. Moll; Janneke J.C. van Lith-Verhoeven; Marcel G.W. Dijkgraaf; Reinier O. Schlingemann

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3648.

Anatomy and Pathology/Oncology July 2000

Expression of Epidermal Growth Factor Receptor: Risk Factor in Uveal Melanoma

PDF

H. Monique H. Hurks; Jessica A. W. Metzelaar-Blok; Ed R. Barthen; Aeilko H. Zwinderman; Didi De Wolff-Rouendaal; Jan E. E. Keunen; Martine J. Jager
TAGS: epidermal growth factor receptors, intraocular melanoma, risk factors, neoplasms, histopathology tests
Invest. Ophthalmol. Vis. Sci.. 2000; 41(8):2023-2027.

Articles August 1997

Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.

PDF

D J Blom; G P Luyten; C Mooy; S Kerkvliet; A H Zwinderman; M J Jager
TAGS: human leukocyte antigen class i, intraocular melanoma
Invest. Ophthalmol. Vis. Sci.. 1997; 38(9):1865-1872.

Advertisement